RMTI stock forecast
Our latest prediction for Rockwell Medical, Inc.'s stock price was made on the Aug. 2, 2019 when the stock price was at 2.45$.
In the short term (2weeks), RMTI's stock price should outperform the market by 4.23%. During that period the price should oscillate between -8.12% and +16.07%.
In the medium term (3months), RMTI's stock price should outperform the market by 7.33%. During that period the price should oscillate between -18.25% and +40.83%.Get email alerts
About Rockwell Medical, Inc.
Rockwell Medical, Inc. engages in targeting end-stage renal disease and chronic kidney disease. Its dialysis products include hemodialysis concentrates, citrapure, dri-sate, safety data sheets,ancillary products, and renal pure. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
At the moment the company generates 64M USD in revenues.
On its last earning announcement, the company reported a loss of -0.65$ per share.
The book value per share is 0.33$
Three months stock forecastAug. 2, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|